Lexicon Pharmaceuticals (LXRX) EPS (Basic): 2009-2011
Historic EPS (Basic) for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$0.10.
- Lexicon Pharmaceuticals' EPS (Basic) fell 42.86% to -$0.10 in Q4 2011 from the same period last year, while for Dec 2011 it was $337,527, marking a year-over-year increase of 71.13%. This contributed to the annual value of -$0.34 for FY2011, which is negligibly% changed negligibly from last year.
- Per Lexicon Pharmaceuticals' latest filing, its EPS (Basic) stood at -$0.10 for Q4 2011, which was down 25.00% from -$0.08 recorded in Q3 2011.
- In the past 5 years, Lexicon Pharmaceuticals' EPS (Basic) registered a high of $337,527 during Q1 2011, and its lowest value of -$1.01 during Q4 2009.
- Moreover, its 3-year median value for EPS (Basic) was -$0.07 (2010), whereas its average is $48,615.
- Data for Lexicon Pharmaceuticals' EPS (Basic) shows a peak YoY increase of 123,274,275.00% (in 2010) and a maximum YoY decrease of 157.14% (in 2010) over the last 5 years.
- Over the past 3 years, Lexicon Pharmaceuticals' EPS (Basic) (Quarterly) stood at -$1.01 in 2009, then surged by 93.07% to -$0.07 in 2010, then crashed by 42.86% to -$0.10 in 2011.
- Its EPS (Basic) stands at -$0.10 for Q4 2011, versus -$0.08 for Q3 2011 and -$0.08 for Q2 2011.